生命银行
心肌梗塞
蛋白质组学
医学
内科学
弗雷明翰风险评分
风险评估
生物信息学
生物标志物
血液蛋白质类
预测建模
入射(几何)
肿瘤科
蛋白质组
风险因素
风险模型
定量蛋白质组学
计算生物学
生物标志物发现
心脏病学
机器学习
多基因风险评分
蛋白质表达
作者
Neil Wright,Mohsen Mazidi,Alfred Pozarickij,Pang Yao,Christiana Kartsonaki,Iona Y. Millwood,Andri Iona,Hannah Fry,Pei Pei,Yiping Chen,Baihan Wang,Daniel Avery,Dan Schmidt,Huaidong Du,Ling Yang,Yali Yan,Jun Lv,Canqing Yu,Dianjianyi Sun,Junshi Chen
标识
DOI:10.1093/gigascience/giag102
摘要
BACKGROUND: Advances in proteomics assays enable measurement of thousands of plasma proteins, which could facilitate machine learning-based approaches to enhance risk prediction of disease. METHODS: We measured plasma levels of >9500 proteins among 4000 Chinese adults (1937 myocardial infarction [MI] cases and 2026 subcohort), using both Olink Explore (2923 proteins) and SomaScan (6597 proteins) platforms. Protein-based risk prediction models were constructed, using conventional and machine learning approaches, with model performance assessed via discrimination (C-statistic), classification (net reclassification index; NRI) and calibration. Protein scores were compared and combined with conventional risk factors and polygenic scores (PGS), and externally validated in 37,187 Europeans (630 MI cases) in UK Biobank. FINDINGS: Overall, 451 Olink and 530 SomaScan proteins were significantly associated (5% false discovery rate) with MI risk after adjustment for conventional risk factors. The protein prediction models based on Olink, SomaScan, or both platforms combined, outperformed conventional risk factors and PGS using discrimination, classification and calibration. The protein score using 23 Boruta-selected (Olink/SomaScan: 11/12) proteins yielded a 3.3-fold difference in 10-year cumulative incidence of MI between the top and bottom 20% risk groups (3.6 [95%CI: 3.1-4.1] vs 1.1 [0.9-1.2] per 100), compared with 2.5-fold (2.5 [2.2-2.9] vs 1.0 [0.9-1.2]) and 1.5-fold (1.9 [1.6-2.1] vs 1.3 [1.1-1.4]) differences for conventional and PGS, respectively. Adding this protein score to conventional risk factors increased C-statistics from 0.846 (0.829-0.862) to 0.864 (0.849-0.879), yielding an NRI of 72%. External validation in 37,187 participants in UK Biobank by adding 23 Boruta-selected proteins to conventional risk factors yielded comparable improvement in C-statistics for MI (from 0.710 [0.688-0.731] to 0.733 [0.710-0.756]) and 45% improvement in NRI (NRI 45%). CONCLUSIONS: Machine learning identified subsets of proteins for improved MI risk prediction beyond conventional risk factors and PGS, showing the potential for developing small panel proteomics assays to improve disease risk prediction.
科研通智能强力驱动
Strongly Powered by AbleSci AI